CIK 0000899923 · Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870494517
- Phone
- 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- DEF 14A Proxy Proxy Statement
- 4 Shares withheld for taxes Chief Scientific Officer gave up 940 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 1,076 shares (to pay taxes)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes Chief Accounting Officer gave up 581 shares (to pay taxes)
- 4/A Grant or award Chief Financial Officer acquired 46,905 shares (grant or award)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 363 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 1,441 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 1,344 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief of Staff gave up 730 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technology Officer gave up 4,575 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 2,348 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 4,893 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 66,024 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 2,568 shares (to pay taxes)
- 4 Grant or award Chief Accounting Officer acquired 7,500 shares (grant or award)
- 4 Shares withheld for taxes SVP, Chief of Staff gave up 1,585 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technology Officer gave up 3,306 shares (to pay taxes)
- 4 Grant or award Chief People Officer acquired 41,042 shares (grant or award)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 3,322 shares (to pay taxes)
Page 13 of 104 · 2,077 filings